|
|||||
|
|
Phase II study of long-term androgen suppression with bevacizumab and intensity-modulated radiation therapy (IMRT) in high-risk prostate cancer |
|
| Authors: | Vuky Jacqueline Pham Huong T Warren Sarah Douglass Erika Badiozamani Kasra Madsen Berit Hsi Alex Song Guobin |
| Affiliation: | Section of Community Hematology/Oncology, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97210, USA. vukyja@ohsu.edu |
| Abstract: | |
| Keywords: | Prostate cancer Bevacizumab Hormonal therapy Radiation therapy |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |